Evidence map›Paper›PMID 32072141›Full record

ArticleHemaSphere2020

HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma.

Wendy B C Stevens, Katerina Bakunina, Marloes Cuijpers, Martine Chamuleau, Aart Beeker, Rob Fijnheer, Holger Hebart, Hein P J Visser, Jeanette K Doorduijn, Kim Linton and 3 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 3 countries.

Wendy B C StevensDepartment of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Katerina BakuninaHOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Marloes CuijpersDepartment of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands.
Martine ChamuleauDepartment of Hematology, Amsterdam UMC, VU MC, Amsterdam, The Netherlands.
Aart BeekerDepartment of Oncology, Spaarne Gasthuis, Hoofddorp, The Netherlands.
Rob FijnheerDepartment of Internal Medicine, Meander Medical Center, Amersfoort, The Netherlands.
Holger HebartDepartment of Internal Medicine, Stauferklinikum Schwäbisch Gmünd, Mutlangen, Germany.
Hein P J VisserDepartment of Internal Medicine, Tergooi Hospital, Hilversum, The Netherlands.
Jeanette K DoorduijnDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Kim LintonManchester Cancer Research Centre, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Martin DreylingDepartment of Medicine III, University hospital, LMU Munich, Germany.
Daphne de JongDepartment of Pathology, Amsterdam UMC, VU MC, Amsterdam, The Netherlands.
Marie José KerstenDepartment of Hematology, Amsterdam UMC, University of Amsterdam and Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
Erasmus MC Cancer Institute · NLRijnstate Hospital · NLAmsterdam UMC Location VUmc · NLLMU Klinikum · DEMeander Medisch Centrum · NLRadboud University Medical Center · NLRadboud University Nijmegen · NLSpaarne Ziekenhuis · NLTergooi · NLThe Christie NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32072141
PMCPMC7000479
OpenAlexW3004374656

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.